Clinical Trial Update: Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a next-generation sequencing-based 'Oncochip' to guide therapeutic decisions in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING